Notice of Intent to Publish a Funding Opportunity Announcement for Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early Stage Development (UG3/UH3 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

NOTE: This is a Forecasted Opportunity.

The NIH Countermeasures Against Chemical Threats (CounterACT) program intends to publish a Funding Opportunity Announcement (FOA) to solicit applications for the discovery and early-stage development of safe and effective new and repurposed drug candidates to mitigate the health effects resulting from exposure to highly toxic chemical threats. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in spring 2022 with an expected application due date in fall 2022. NIH is planning a Webinar to describe this funding opportunity to future applicants when the funding opportunity is published.

 

Estimated Post Date: May 03, 2022
Estimated Application Due Date: Sep 13, 2022

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 13, 2022